Azithromycin for coronavirus treatment

Azithromycin presents in vitro activity against SARS-CoV-2 and could act in different points of the viral cycle. This systematic review and meta-analysis summarizes the available evidence to date on the beneficial and adverse effects of azithromycin in patients with COVID-19

2024-03-19
    Transdermal oxybutynin for overactive bladder
  1. Abstract
  2. abdominal (belly) pain
  3. 2021;397 (10279):1063-1074
  4. In this review, we critically appraise the current
  5. A team of UC Davis Health clinicians and data scientists
  6. Food and Drug Administration has approved drug Patients and methods
  7. K